| Similar Articles |
|---|
 |
The Motley Fool
June 2, 2011
Dee Gill |
CVS's Improved Performance Begins to Drown Out the Dump-Caremark Chants Is the prognosis for CVS looking up?   |
The Motley Fool
January 8, 2007
Matthew Crews |
CVS' Tightrope Walk The drugstore chain's aggressive growth strategy continues to pay off -- for now. Investors, take note. |
The Motley Fool
August 1, 2007
Ryan Fuhrmann |
Foolish Forecast: CVS Caremark Gets Ready to Rumble CVS Caremark will announce its first combined quarterly results tomorrow. Competitors will be watching to see if the merger of drugstore chain and pharmacy benefit manager is a healthy one. |
BusinessWeek
September 19, 2005
Gene G. Marcial |
CVS' Ever-Expanding Aisles According to analysts, the aging population and improving pipeline of new drugs will help the retail pharmacy achieve its goal of 15% overall long-term earnings growth. Investors, take note. |
The Motley Fool
March 26, 2010
Cathy Applefeld Olson |
Can CVS Caremark Win the Drug Wars? Now that health-care legislation has been signed into law, it's a perfect time to give the country's largest drugstore chain a checkup. |
The Motley Fool
June 14, 2010
Jennifer Schonberger |
The S&P 500's Biggest Movers Gannett was among the companies making a move up. |
The Motley Fool
April 9, 2007
Mike Cianciolo |
CVS: Continued Vigorous Sales The drugstore chain grows sales and itself in March. Investors, take note. |
The Motley Fool
November 5, 2007
Timothy M. Otte |
CVS Is in the Zone Pharmacy giant CVS grew EPS by 36% in the third quarter. The company has been on a roll since its merger with Caremark last year. |
The Motley Fool
August 8, 2005
Mike Cianciolo |
A Cautiously Optimistic CVS The retail pharmacy nudges guidance up after an impressive quarter. All things considered, the outlook seems bright for investors in this company. |
The Motley Fool
May 2, 2008
Timothy M. Otte |
CVS Caremark and the Snickers Factor The soft economy has hit some retail sectors hard. But there are still pockets of life, and CVS Caremark is one of the companies leading the way. |
The Motley Fool
May 8, 2007
Ryan Fuhrmann |
CVS/Caremark Tie the Knot While it's too early to see if CVS blazed a new health-care trail by combining a drugstore chain with giant pharmacy benefit manager Caremark, there are still interesting tidbits to pass along to investors from recently reported results. |
The Motley Fool
June 10, 2010
Claire Stephanic |
CVS Caremark vs. Walgreen The two go head-to-head in competition for pharmacy customers. |
The Motley Fool
November 2, 2006
Ryan Fuhrmann |
CVS Blazes a New Healthcare Trail Strong third-quarter earnings aside, the merger announcement with pharmacy benefit manager Caremark was the real shocker here. Investors, take note. |
The Motley Fool
December 19, 2006
Matthew Crews |
Express Scripts' Takeover Battle The pharmacy benefits manager challenges CVS with a higher bid for rival Caremark RX. Investors, stay tuned -- this is far from over. |
CIO
April 27, 2011
Stephanie Overby |
How to Bring Outsourced Services Back In-House Major mergers created both a need and an opportunity for CVS Caremark to bring an outsourced data center back in-house. |
The Motley Fool
October 31, 2008
Timothy M. Otte |
CVS Caremark Takes Care of Its Investors The drugstore giant continues to scoop up market share. |
The Motley Fool
August 31, 2011
Shubh Datta |
CVS Caremark Flattened by Higher Costs CVS Caremark profits remained relatively flat this quarter despite a substantial increase in revenue. |
The Motley Fool
October 2, 2011
Shubh Datta |
Would You Invest in This Drug Retailer? Is CVS Caremark worth your investment? |
The Motley Fool
May 4, 2011
Jason Knapp |
Generic Drugs and Old People Could Make You Rich CVS hasn't generated market-beating returns yet -- but it will. |
The Motley Fool
August 3, 2007
Ryan Fuhrmann |
CVS Caremark Is No Sicko Pharmacy powerhouse CVS Caremark is looking to blaze a new health-care trail with the recent merger of their drugstore and pharmacy benefit management operations. |
The Motley Fool
May 9, 2005
Timothy M. Otte |
Flu Means All's Well for CVS Strong comp sales and benefits from the Eckerd acquisition drive CVS to a solid first quarter. Investors, take note. |
The Motley Fool
November 17, 2008
Alex Dumortier |
Bank Execs Forgo Bonuses, but Does It Matter? Goldman Sachs announces that seven of its top executives, including CEO Lloyd Blankfein, will forgo bonuses this year. Expect others to follow. |
The Motley Fool
October 5, 2007
Timothy M. Otte |
CVS: Consistently Very Solid The drugstore giant scores a consistent sales increase in September, as it begins to capitalize on synergies from its CareMark acquisition. |
The Motley Fool
February 4, 2008
Timothy M. Otte |
CVS Has Major Mo' Fourth-quarter results cap a stellar year for the drugstore retailer. |
The Motley Fool
June 14, 2010
Rich Smith |
Is CVS' $2 Billion Buyback Good Medicine? Don't assume just because CVS is buying its stock, that this is a good idea. |
The Motley Fool
February 3, 2010
Rich Smith |
What in the World Is Goldman Sachs Thinking? You heard it here first: The recession is over and other stock predictions from Goldman Sachs. |
Registered Rep.
January 20, 2004
David A. Gaffen |
UBS Adds HNW Reps in San Fran, Atlanta UBS Securities, which has been one of the most aggressive recruiters of the last year or so in the retail brokerage business, continued its hiring efforts, recently bringing on two large producers from Goldman Sachs. |
The Motley Fool
May 5, 2004
Mike Cianciolo |
CVS Prescribes Growth The soon-to-be leader of the drugstore market had a spectacular first quarter as a result of improved sales and margins, and CVS doesn't appear to be showing any signs of slowing down either, as the company continues to expand its business in both traditional and creative ways. |
The Motley Fool
March 22, 2010
Dave Mock |
A Big Upgrade for CVS Caremark This bullish call comes from more than just one analyst. |
The Motley Fool
February 2, 2005
Alyce Lomax |
CVS's Shot in the Arm Buying the Eckerd drugstore chain from J.C. Penney was apparently a good move for CVS. It continues to benefit from the purchase, reporting positive earnings and beating analysts' expectations by a penny. |
The Motley Fool
June 24, 2008
Morgan Housel |
Goldman Sachs: Open Mouth, Insert Foot Everyone makes mistakes. Some are embarrassing. Some are kind of funny. Goldman Sachs' recent mistake may cost investors a lot of money. |
The Motley Fool
January 23, 2006
Tim Beyers |
SUPERVALU Goes Shopping The retailer snaps up Albertsons, but CVS gets the spoils. Investors, take note. |
The Motley Fool
November 10, 2004
Dave Marino-Nachison |
Investors Adjusting to Larger CVS The drugstore company's chains have done nothing but rise since the Eckerd buy. Investors have pulled the company's shares steadily upward since the merger closed. |
The Motley Fool
February 2, 2007
Ryan Fuhrmann |
Uncertain Outlook on CVS Has the retail pharmacy bit off more than it can chew? Investors may soon look back longingly to the day when CVS focused as much on organic, or internal, means to grow its business as it does on acquisitions to buy outside market share. |
The Motley Fool
June 10, 2004
Alyce Lomax |
Summer Starts at CVS The drugstore company releases same-store sales results on the cusp of its Eckerd acquisition. |
The Motley Fool
July 25, 2011
Brian Orelli |
Express-Medco: Just What the Doctor Prescribed In perhaps the most obviously beneficial merger ever, Express Scripts announced its plan to buy Medco Health Solutions for $29.1 billion. |
The Motley Fool
March 20, 2007
Matt Koppenheffer |
The M&A Mix Tape A rockin' review of what dealmakers have been doing over the past week. "Don't Cha" by the Pussycat Dolls featuring IntercontinentalExchange... "Come Together" by The Beatles featuring Cisco Systems... etc. |
The Motley Fool
March 14, 2006
Stephen D. Simpson |
Golden Days for Goldman Sachs All of this leading investment bank's cylinders seem to be firing. Even though the stock has had a pretty fair run already, it wouldn't be a surprise to see share prices continue to rise. |
The Motley Fool
November 4, 2008
Alex Dumortier |
The Market Is Wrong on UBS UBS appears to have turned the corner in restoring investor confidence, but do fundamentals back this up? |
CFO
January 10, 2007
Roy Harris |
The Year of Living Strategically While private-equity bids got lots of attention, some public-company mergers aimed to remake their industries in 2006. |
The Motley Fool
April 21, 2011
Matt Koppenheffer |
A Great New Model for Investment Banks UBS is charging ahead with a leadership position in helping the world understand what investment banks are really all about. |
The Motley Fool
December 26, 2006
Matthew Crews |
Walgreen Represents This drugstore business has proven itself; does its stock match up? |
The Motley Fool
October 8, 2011
Shubh Datta |
Impasse Hurts Walgreen's Quarter Walgreen posted a staggering 69% earnings jump but still saw its shares slide. |
The Motley Fool
December 13, 2006
Tom Taulli |
Goldman's Profit Explosion Goldman hasn't lost its golden touch, as seen with its end-of-the-year results for 2006. It's tough for individual investors to participate in these areas, but investing in Goldman Sachs is one way to get some exposure to them. |
The Motley Fool
August 9, 2011
Seth Jayson |
A Hidden Reason That CVS Caremark's Earnings Are Outstanding With both 12-month and quarterly CCC running better than average, CVS Caremark gets high marks in this cash-conversion checkup. |
InternetNews
February 2, 2010 |
Codesion Steps Out From CVS's Shadow Everyone knows that CVS is a legacy tech for code repositories, right? |
Registered Rep.
June 1, 2006
John Churchill |
Goaallllll! Two financial-services giants, Goldman Sachs and UBS, have put their analysts to work on the outcome of "the beautiful game's" most anticipated event, the World Cup. The results? Two wildly different predictions. |
The Motley Fool
June 2, 2011
Seth Jayson |
One Reason the Street Should Love CVS Caremark's Earnings With both 12-month and quarterly CCC running better than average, CVS Caremark gets high marks in this cash-conversion checkup. |
The Motley Fool
September 16, 2008
Morgan Housel |
Goldman Feels the Heat Though it wasn't a terrible quarter for Goldman Sachs, it's become apparent that banking is a terrible industry right now. And after a crazy week, some question even Goldman Sachs' future. |
The Motley Fool
August 15, 2005
Bobby Shethia |
Walgreen's Prescription for Success The drugstore chain's smart and steady growth makes it a good choice for investors. |
